摘要 |
Novel compounds of the formula I in which R1, R2, R2', R2'', R3, R4, R5, R5', R5'', R5''', R5'''', X, Y, U, V and W are as defined in Patent claim 1, are inhibitors of coagulation factors Xa and VIIa and can be employed fr the treatment of thromboses, myocardilal infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, tumours, tumour diseases and/or tumour metastases.
|